Jenkem Technology Co., Ltd.

Shanghai Stock Exchange 688356.SS

Jenkem Technology Co., Ltd. Revenue Per Share for the year ending December 31, 2023: USD 0.68

Jenkem Technology Co., Ltd. Revenue Per Share is USD 0.68 for the year ending December 31, 2023, a -30.51% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

Jenkem Technology Co., Ltd. Revenue Per Share for the year ending December 31, 2022 was USD 0.98, a 6.63% change year over year.
Jenkem Technology Co., Ltd. Revenue Per Share for the year ending December 31, 2021 was USD 0.92, a 93.32% change year over year.
Jenkem Technology Co., Ltd. Revenue Per Share for the year ending December 31, 2020 was USD 0.48, a 48.23% change year over year.
Jenkem Technology Co., Ltd. Revenue Per Share for the year ending December 31, 2019 was USD 0.32, a -2.24% change year over year.

Key data

Date	Revenue Per Share	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)

Shanghai Stock Exchange: 688356.SS

Jenkem Technology Co., Ltd.

CEO	Mr. Xuan Zhao
IPO Date	Aug. 26, 2020
Location	China
Headquarters	Building C-1
Employees	298
Sector	Health Care
Industries Biotechnology Chemicals & Advanced Materials Pharmaceuticals

Description

Jenkem Technology Co., Ltd. develops and manufactures polyethylene glycol derivative (PEG) products in China. The company offers branched, linear, double substituted, heterofunctional double substituted, multi-arm, multi-arm hetero functional double substituted, and monodisperse PEG products, as well as amino, sulfhydryl, and N-terminal pegylated PEG products. It also provides PEGylation services for proteins, peptides, oligonucleotides, and small molecules, as well as custom PEG synthesis of PEG derivatives. The company was founded in 2001 and is based in Beijing, China.

Key trends

Past 5 years